Similar articles

• Oligonucleoside boranophosphate (borane phosphonate).

  Shaw BR, Madison J, Sood A, Spielvogel BF. Shaw BR, et al. Methods Mol Biol. 1993;20:225-43. doi: 10.1385/0-89603-281-7:225. Methods Mol Biol. 1993. PMID: 8242139 No abstract available.
• Carboranyl oligonucleotides. 3. Biochemical properties of oligonucleotides containing 5-(o-carboranyl-1-yl)-2'-deoxyuridine.

  Lesnikowski ZJ, Fulcrand G, Lloyd RM Jr, Juodawlkis A, Schinazi RF. Lesnikowski ZJ, et al. Biochemistry. 1996 May 7;35(18):5741-6. doi: 10.1021/bi953078e. Biochemistry. 1996. PMID: 8639534
• Boronated DNA-binding compounds as potential agents for boron neutron capture therapy.

  Crossley EL, Ziolkowski EJ, Coderre JA, Rendina LM. Crossley EL, et al. Mini Rev Med Chem. 2007 Mar;7(3):303-13. doi: 10.2174/138955707780059808. Mini Rev Med Chem. 2007. PMID: 17346220 Review.
• Carboranyl oligonucleotides: 4. synthesis and physicochemical studies of oligonucleotides containing 2'-O-(o-carboran-1-yl)methyl group.

  Olejniczak AB, Koziolkiewicz M, Lesnikowski ZJ. Olejniczak AB, et al. Antisense Nucleic Acid Drug Dev. 2002 Apr;12(2):79-94. doi: 10.1089/108729002760070821. Antisense Nucleic Acid Drug Dev. 2002. PMID: 12074368
• Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy.

  Sjöberg S, Carlsson J, Ghaneolhosseini H, Gedda L, Hartman T, Malmquist J, Naeslund C, Olsson P, Tjarks W. Sjöberg S, et al. J Neurooncol. 1997 May;33(1-2):41-52. doi: 10.1023/a:1005756929011. J Neurooncol. 1997. PMID: 9151222 Review.